SAFE & EFFECTIVE LONG-TERM
GENE THERAPY TECHNOLOGY
Global BioTherapeutics (GBT) is a biotechnology company that is developing a gene delivery platform that will revolutionize the field of gene therapy and may finally allow patients to realize the potential of gene therapy to treat genetic diseases and chronic illnesses. GBT has spent ten years addressing the fundamental question of how to achieve safe, long term gene expression. GBT's gene therapy platform, unlike any other, minimizes many of the major risks associated with gene therapy today. Most importantly, GBT has demonstrated the safe and effective delivery and long-term expression of reporter genes for intracellular and secreted proteins.